CNS Pharmaceuticals Inc (CNSP) USD0.001

Sell:$0.11Buy:$0.12$0.01 (5.41%)

Prices delayed by at least 15 minutes
Sell:$0.11
Buy:$0.12
Change:$0.01 (5.41%)
Prices delayed by at least 15 minutes
Sell:$0.11
Buy:$0.12
Change:$0.01 (5.41%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
1 February 2024
John Michael ClimacoChairman/CEO
Buy
Regular purchase transaction
166,666$0.30$49,999.80215,676
1 February 2024
Christopher S DownsCFO
Buy
Regular purchase transaction
66,666$0.30$19,999.80103,438
1 February 2024
Jerzy (George) GumulkaIndependent Director
Buy
Regular purchase transaction
33,333$0.30$9,999.9043,006
1 February 2024
Carl Anthony EvansDirector
Buy
Regular purchase transaction
33,333$0.30$9,999.9033,458

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
1 February 2024
John Michael ClimacoChairman/CEO
Buy
Regular purchase transaction
166,666$0.30$49,999.80215,676
1 February 2024
Christopher S DownsCFO
Buy
Regular purchase transaction
66,666$0.30$19,999.80103,438
1 February 2024
Jerzy (George) GumulkaIndependent Director
Buy
Regular purchase transaction
33,333$0.30$9,999.9043,006
1 February 2024
Carl Anthony EvansDirector
Buy
Regular purchase transaction
33,333$0.30$9,999.9033,458

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.